MORN MORN
Company Profile ↓Company Overview
MORN (MORN) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 30.3%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 20.8%.
Maintains a net profit margin of 15.1%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $2.45B (+7.5% YoY).
- Trailing 12 Months Year-on-year growth — revenue +7.5%, earnings +162.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 9.8%, profit CAGR 9.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 9.76% |
| 1 Year: | 7.49% |
Compounded Profit Growth
| 5 Years: | 9.26% |
| 1 Year: | 162.15% |
Stock Price Performance
| 1 Year: | -25.52% |
| 6 Months: | +11.16% |
| 3 Months: | +20.03% |
| 1 Month: | +16.94% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)68.35 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 30.3%.
- Healthy ROCE of 20.8%.
- Generates positive free cash flow.
CONS
- Trading 25.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 209.50M | 229.20M | 229.90M | - | 243.50M | 252.40M | 261.30M | - | 258.90M | 273.90M | 313.80M | - | 324.00M | 327.90M | 357.20M | - | 392.80M | 415.40M | 428.90M | 457.00M | 470.40M | 468.20M | 479.70M | 504.70M | 515.50M | 542.80M | 571.90M | 569.40M | 581.90M | 605.10M | 617.40M | 644.80M | 663.20M |
| Operating Income | 49.70M | 46.20M | 50.10M | 42.30M | 44.40M | 44.20M | 49.90M | 28.40M | 46.00M | 52.80M | 42.60M | 47.50M | 53.60M | 65.40M | 49.30M | 49.50M | 50.80M | 49.60M | 39.70M | 44.50M | 61.30M | 44.30M | 65.10M | 67.20M | 47.20M | 67.80M | 56.40M | 53.90M | 22.00M | 24.50M | 41.70M | 70.00M | 92.60M | 108.50M | 115.50M | 114.10M | 125.10M | 127.80M | 155.90M | 160.60M |
| Net Income | 32.20M | 33.50M | 37.30M | 28.70M | 31.80M | 30.20M | 70.30M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted EPS | 0.72 | 0.76 | - | 0.67 | 0.73 | 0.70 | - | 0.42 | 1.07 | 0.79 | - | 0.98 | 0.97 | 1.32 | - | 0.77 | 0.98 | 1.14 | - | 0.55 | 1.12 | 1.76 | - | 1.27 | 0.76 | 1.13 | 1.06 | 0.70 | -0.21 | -0.18 | 0.84 | 0.91 | 1.49 | 1.60 | 2.77 | 1.82 | 2.09 | 2.17 | 2.73 | 2.83 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 502.46M | 479.00M | 555.35M | 631.40M | 658.29M | 698.30M | 760.10M | 788.80M | 798.60M | 911.70M | 1.02B | 1.18B | 1.39B | 1.70B | 1.87B | 2.04B | 2.28B | 2.45B |
| Operating Income | 138.88M | 124.67M | 121.06M | 138.41M | 150.67M | 170.70M | 105.60M | 190.60M | 180.80M | 169.80M | 215.80M | 189.60M | 215.20M | 257.00M | 167.80M | 230.60M | 484.80M | 526.60M |
| Net Income | 89.63M | 82.13M | 86.37M | 98.36M | 108.08M | 123.50M | 78.30M | 132.60M | 161.00M | 136.90M | 183.00M | 152.00M | 223.60M | 193.30M | 70.50M | 141.10M | 369.90M | - |
| Diluted EPS | 1.82 | 1.65 | 1.70 | 1.92 | 2.20 | 2.66 | 1.74 | 3.00 | 3.72 | 3.18 | 4.25 | 3.52 | 5.18 | 4.45 | 1.64 | 3.29 | 8.58 | 8.87 |
| R&D Expense | 40.34M | 38.38M | 49.24M | 53.16M | 51.44M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 919.08M | 1.09B | 1.17B | 1.04B | 1.03B | 1.01B | 1.03B | 1.35B | 1.41B | 1.45B | 2.37B | 2.70B | 2.86B | 3.47B | 3.40B | 3.55B | 3.59B |
| Total Equity | 402.42M | 530.25M | 664.62M | 780.32M | 855.37M | 725.52M | 690.26M | 653.50M | 640.30M | 696.50M | 804.90M | 934.70M | 1.08B | 1.27B | 1.42B | 1.21B | 1.33B | 1.62B | 1.22B |
| Cash & Equivalents | 159.58M | 173.89M | 130.50M | 180.18M | 200.44M | 163.90M | 168.20M | 185.20M | 207.10M | 259.10M | 308.20M | 369.30M | 334.10M | 422.50M | 483.80M | 376.60M | 337.90M | 502.70M | 474.50M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 70.00M | 502.10M | 449.10M | 359.40M | 1.11B | 972.40M | 698.60M | 1.07B |
| Total Liabilities | - | - | 253.29M | 304.88M | 315.07M | 315.06M | 339.38M | 355.90M | 388.40M | 654.10M | 600.80M | 519.10M | 1.29B | 1.42B | 1.45B | 2.27B | 2.08B | 1.93B | 2.37B |
| Current Liabilities | - | - | 207.50M | 252.72M | 270.63M | 257.37M | 269.55M | 293.80M | 304.40M | 294.90M | 323.20M | 362.80M | 495.80M | 626.50M | 783.50M | 882.50M | 880.80M | 967.30M | 1.05B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 149.34M | 101.26M | 123.42M | 164.98M | 146.00M | 186.70M | 136.60M | 241.50M | 213.70M | 250.10M | 314.80M | 334.40M | 384.30M | 449.90M | 297.80M | 316.40M | 591.60M | 589.70M |
| Investing Cash Flow | -179.12M | -174.68M | -87.95M | -110.77M | 80.19M | -14.90M | -31.20M | -79.50M | -274.20M | -60.80M | -49.90M | -746.30M | -123.80M | -167.70M | -799.30M | -81.90M | -21.30M | -139.30M |
| Financing Cash Flow | 50.74M | 25.32M | 12.53M | -32.60M | -265.18M | -166.40M | -76.10M | -127.50M | 123.70M | -157.50M | -188.80M | 373.70M | -182.20M | -211.80M | 415.10M | -278.40M | -384.40M | -514.70M |
| Capital Expenditure | - | -12.37M | -14.77M | -23.32M | -30.04M | -33.60M | -58.30M | -57.30M | -62.80M | -66.60M | -76.10M | -80.00M | -76.70M | -101.80M | -129.50M | -119.10M | -142.70M | -147.10M |
| Free Cash Flow | - | 88.88M | 108.64M | 141.65M | 115.96M | 153.10M | 78.30M | 184.20M | 150.90M | 183.50M | 238.70M | 254.40M | 307.60M | 348.10M | 168.30M | 197.30M | 448.90M | 442.60M |
| Share Buybacks | - | 0 | 3.79M | 40.67M | 251.81M | 153.50M | 76.70M | 97.00M | 48.80M | 42.30M | 20.90M | 4.90M | 41.90M | 1.30M | 226.00M | 1.40M | 11.60M | 787.00M |
| Dividends Paid | - | 0 | 0 | 10.04M | 25.49M | 17.40M | 30.50M | 33.70M | 37.90M | 39.30M | 42.60M | 47.80M | 51.40M | 54.20M | 61.50M | 63.90M | 69.30M | 76.90M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 27.6% | 26.0% | 21.8% | 21.9% | 22.9% | 24.4% | 13.9% | 24.2% | 22.6% | 18.6% | 21.2% | 16.1% | 15.5% | 15.1% | 9.0% | 11.3% | 21.3% | 21.5% |
| Net Margin % | 17.8% | 17.1% | 15.6% | 15.6% | 16.4% | 17.7% | 10.3% | 16.8% | 20.2% | 15.0% | 17.9% | 12.9% | 16.1% | 11.4% | 3.8% | 6.9% | 16.3% | - |
| ROE % | 16.9% | 12.4% | 11.1% | 11.5% | 14.9% | 17.9% | 12.0% | 20.7% | 23.1% | 17.0% | 19.6% | 14.0% | 17.6% | 13.7% | 5.8% | 10.6% | 22.9% | - |
| ROCE % | - | 17.5% | 14.5% | 15.4% | 19.2% | 22.4% | 14.7% | 26.3% | 17.1% | 15.7% | 19.8% | 10.1% | 10.4% | 12.4% | 6.5% | 9.1% | 18.8% | 20.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MORN
Insider Sale: Executive Chairman of $MORN Sells 1,246 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQV1JNUEdZRW84RzNyZGk0cFBQN09PaWxXMXNNMWg5dlVxT1drMVRTcUxxMWxYNTM0QnpaLVFFQl9TTWRXbXZGRU83QS1ydURFLWdpY1M4MHJDWDN0MVNxZC03WUw3MjlXbWRVNWRqemIwLVpiaW9PYVd3cmJBMlhONmhLWXpfeHRGcmVZaE…
Morningstar Stock Price Forecast. Should You Buy MORN? - StockInvest.us
<a href="https://news.google.com/rss/articles/CBMiSEFVX3lxTE44SFJPcUlhRnAyamNYaUtEcXp3VVVaYjFjaHdpTkE2MGhVZEM2UVRrNUs1a295RFQtQjhJdUg3UnAwdHRMZTRPZw?oc=5" target="_blank">Morningstar Stock Price Forecast. Should You Buy MORN?</a>  …
Morningstar (MORN) Stock Looks Fully Priced As Shares Fell 37% - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPbHF6Vm9RRmtMUlp1N0lpb2JCYU44eEtpNUVQTFpFVW1FVDVOU2xnbHlsZWE4SVcxZE1adVVjdzRJa29raFpfTGlWamdnSjJfa1Y1dXhrR2RfZXduLXcxZHdYMUUwR3FwaHJWV2E1emktdy0xaTh3UldIZjVOU014aWZ4X3JBLUl5NVBqVD…
Morningstar, Inc. (MORN) director disposes of 1,000 common shares at $199 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNWnVzZnBJRU9lZy1uamhOU1NJVFdKdVVNM0VJV3Zua1ZheEplQVJvelFXWFlJM2lmRWM5QWZ3QTRjekIzR0dYYUViMm1UXzQzNi1JejVpMm1KRGc5MDVWNXNtYmt4djQ2WFE1b2d4Qk8zeGFuUTRiNlFVWktpS1VkTWVnM2E4dUVTVE96S0…
Morningstar (MORN) Stock Price Dips As Earnings Strength Holds - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxOem5VQ0lFRldRTVJyNGgzbVBpV09reVJPWkdwLU9RZTQ5LTNWeVlxMnUySVR4aEdjQ2ZjU0taUjNob2VHRmh5dXJ0WmhKSklWODdCN2sya3E2NnRoU1JKU0NCZ0JBWUJaY0ZaZFBCcEVuV0dabklSamhWWFVEWU5SZFgzRXNvdGIxdGg5Um…
Morningstar: Undervalued With A Differentiated Business Model (NASDAQ:MORN) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQNnJmazY0Vk0xZGdRdDhBbllEX3dBOGZuRU5MUnFfa2JWdW1mN2xqR3ZVcmZrTEJ2YlJuNHpqc3FZYmszeFJOZUt2bW01NzRzZTdmSjZvVWo3ZkplVElJbHZhQWd4dGxLWFFyaEhCZnM2RVhDLXpXb3hSZ3ktOHV5anFNM3hjVnRzRk56Nk…
MORN — Frequently Asked Questions
What is the current share price of MORN?
As of 2026-08-05 17:25 PDT, MORN trades at $199.32 on NASDAQ/NYSE. Its 52-week range is $141.41 to $267.63.
What is the P/E ratio of MORN?
MORN trades at a trailing price-to-earnings (P/E) ratio of 22.47.
What is the return on equity (ROE) of MORN?
MORN has a return on equity (ROE) of 30.27%. Its return on capital employed (ROCE) is 20.76%.
Is MORN a good stock to buy?
This page provides a data-driven analysis of MORN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.